From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

This study looks at how well the drug ropeginterferon alfa-2b works and is tolerated by people with polycythemia vera, a rare blood disorder that raises the risk of blood clots and can turn into more serious disease. About 319 adults who need this treatment will be followed for u…